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Objective: Examine the association of the 4a/4b polymorphism of endothelial nitric oxide synthase
(eNOS) with blood pressure in women at late pregnancy.
Materials and methods: Blood pressure before pregnancy and at the end of gestation (37e40-week term)
was measured in 588 women of the Russian ancestry. The women were divided into groups according to
the body mass index and the presence of preeclampsia at late pregnancy. The 4a/4b polymorphism of the
eNOS gene was genotyped using PCR with subsequent screening of ampliﬁed fragment length
polymorphisms.
Results: The 4a4a eNOS genotype was associated with higher levels of diastolic blood pressure in
pregnant women and with more pronounced dynamics of the diastolic and mean arterial pressure in the
development of pregnancy (p ¼ 0.02e0.03). Pregnant women with the 4a4a genotype and increased
body mass index had higher systolic, diastolic, and mean arterial pressure (p ¼ 0.001e0.009). In pregnant
women with preeclampsia, the 4a4a genotype was associated with higher level of diastolic blood
pressure at the end of pregnancy (p ¼ 0.04), whereas in the women without preeclampsia this genotype
was associated with more pronounced changes of blood pressure at pregnancy (p ¼ 0.02).
Conclusion: The results of our study suggest that the genotype 4a4a of the eNOS gene is associated with
higher levels of blood pressure in women at the end of pregnancy.
© 2019 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Pregnancy is one of the physiological conditions, which requires
long-term and fundamental adjustments of many functional sys-
tems of the organism in order to maintain homeostasis. In the
course of pregnancy, the cardiovascular system experiences an
increased load due to augmented metabolism, larger volume of
circulating blood, development of uteroplacental circulation, gain
in body weight, and elevated production of several hormones [1].
Hypertension is one of the common health complications dur-
ing pregnancy. Its prevalence among pregnant women is 12e22%
[2]. Pregnant women with hypertension are predisposed to severalDepartment of Medical Bio-
Russia. Fax: þ74722301012.
tnikov).
Gynecology. Publishing services bhealth problems, such as placental abruption, disseminated intra-
vascular coagulation (DIC), brain hemorrhage, acute renal failure,
and eclampsia [3e5].
Nitric oxide (NO) is a potent vasodilator synthesized from L-
arginine with the aid of endothelial NO-synthase (eNOS) [6].
The eNOS gene is located on chromosome 7q35-36 and has 26
exons. Among several polymorphisms identiﬁed in the gene,
Glu298Asp (rs1799983) in exon 7, 4a/4b in intron 4, and T2786C
(rs2070744) in the promoter region [7] have been commonly
studied for their association with functions of the cardiovascular
system in healthy and diseased patients [8e10].
Polymorphism 4a/4b is located within theminisatellite in intron
4 of the gene. Its alleles have varying number of 27-bp long tandem
repeats (allele 4a has 4 repeats and allele 4be5 repeats, respec-
tively) [7]. The polymorphismwas associated with a decrease of NO
level in blood plasma, whichwas implicated in respective reduction
of nitrite and nitrate levels [11,12].y Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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have lower concentration and activity of eNOS as compared to
homozygotes 4b4b [11]. Homozygotes 4a4a manifested lower level
of NO in blood plasma as compared to both 4b4b and 4a4b geno-
types [12]. Also, a lower level of NOwas reported in carriers of allele
4a as compared to carriers of allele 4b [13].
The previous studies estimated the frequencies of the 4a/4b
genotypes in a Russian population as 2.0e4.1% for 4а4а, 23.8e29.4%
for 4a4b, and 68.6e72.1% for 4b4b [14,15].
The available data on the association of the 4a/4b polymorphism
with blood pressure in pregnant females are contradictory
[8,16e23]. In this regard, further studies are needed to investigate
the role of this locus in the functioning of the cardiovascular system
in pregnant women.
While there are quite a few studies on association of the 4a/4b
polymorphism in various ethnic populations, no such analysis has
been conducted in Russians. The present study is the ﬁrst, which
examined association of the 4a/4b polymorphism of endothelial
nitric oxide synthase (eNOS) with blood pressure in Russianwomen
at late pregnancy.
Materials and Methods
Study subjects
This study was approved by the Regional Ethics Committee at
Belgorod StateNational ResearchUniversity. An informed consentwas
obtained from each participant prior to the enrollment in the study.
The participants were recruited through the Perinatal Centre of
St. Joasaph Belgorod Regional Clinical Hospital. The eligible par-
ticipants were 588 unrelated women of Russian descent (self-
declared) born in Central Russia [24]. The age of the women varied
from 20 to 43 years (mean age 27.98 ± 4.50 years). Clinical and
laboratory examinations of the participants were conducted at the
Perinatal Centre (Division of Pathological Pregnancy) of St. Joasaph
Belgorod Regional Clinical Hospital. The inclusion criteria were (a)
Russian ethnicity and (b) pregnancy at 37e40 weeks of gestation.
Pregnant women diagnosedwith diabetesmellitus, hepatic or renal
failure were excluded from the study. Blood pressure (BP) level was
measured three times according to the American Heart Association
recommendations [25] by an experienced obstetrician. The mea-
surements were done in the morning (between 07:00e09:00) and
evening (between 19:00e21:00). The data on the BP level before
pregnancy was obtained from the medical records of each partici-
pant. The mean arterial pressure (MAP, mm Hg) was calculated as
follows:MAP¼ (SBPþ2DBP)/3, where SBP is systolic blood pressure
and DBP is diastolic blood pressure.
All study participants were divided into three groups according
to the BP level at the end of pregnancy: normotensive women (SBP
from 90 to 140 mm Hg and/or DBP from 60 to 90 mm Hg), hypo-
tensive women (SBP<90 mm Hg and/or DBP<60 mm Hg), and hy-
pertensive women (SBP>140 mm Hg and/or DBP>90 mm Hg).
All participants were also categorized according to BMI (kg/m2):
underweight (BMI <18.5), normal weight (BMI ¼ 18.5e24.9),
overweight (BMI ¼ 25e29.9), and obese (BMI  30) [26].
Among 591 participants, 209 were with normal gestation and
382 had preeclampsia. Preeclampsia was deﬁned as the presence of
hypertension accompanied by proteinuria (24 h urine protein
excretion above 300 mg [1]).
DNA extraction and genotyping
Blood (8e9ml) was taken from the ulnar vein. Genomic DNAwas
isolated according to Miller et al. [27]. The 4a/4b VNTR poly-
morphism (4a/4b eNOS) for the analysis were selected based on thefollowing criteria [28]: previously reported associations with blood
pressure, regulatory potential, effect on gene expression. Genotyping
of the 4a/4b eNOSwas performed using a polymerase chain reaction
(PCR) assay according to the protocol described elsewhere [29].
Statistical analysis
The correspondence of the allele and genotype frequencies of the
4a/4b eNOS gene polymorphism to the HardyeWeinberg equilibrium
(HWE) was estimated by the chi-square test. The p-values were
adjusted for multiple testing using the Bonferroni correction (pcor).
The distribution of the quantitative traits such as SBP, DBP, MAP and
pulse pressure (the pressure difference between the systolic and
diastolic pressures) before pregnancy and at the end of pregnancy
were analyzed by the ShapiroeWilk's test [30]. Since the values of the
quantitative traits did not follow the normal distribution, they were
described using median (Me) and interquartile range (Q25-Q75) and
compared between the groups using the ManneWhitney test [31].
The linear multiple regression analysis was used to estimate the effect
of age, weight, and eNOS genotypes on the BP parameters in the
participants. As the dependent variable (BP parameters) did not follow
normal distribution, the analysis was performed with the logarith-
mically transformed values. All statistical analyses were conducted
using STATISTICA for Windows v. 6.0 (StatSoft, USA).
Results
The biomedical and clinical characteristics of the study partici-
pants are shown in Table 1.
The prevalence of hypertension before pregnancy and at the end
of pregnancy among the women was 10.3% and 51.7%, respectively.
The prevalence of hypotension dropped from 19.1% prior to preg-
nancy to 4.1% at the end of pregnancy. Overall, blood pressure
tended to increase towards the end of pregnancy as compared to
that prior to pregnancy. Obesity was determined in 20.6% of the
participants (BMI>30 kg/m2); 15.1% of the participants were over-
weight (BMI ¼ 25e29.9 kg/m2) and 8.1% were underweight
(BMI<18.5 kg/m2); 7.8% of the women had somatic diseases
(vegetative-vascular dystonia, chronic glomerulonephritis, chronic
pyelonephritis, chronic cystitis, polycystic kidney disease, hydro-
nephrosis, pyelectasis).
The observed allele and genotype frequencies were in the
HardyeWeinberg equilibrium. The frequency of allele 4b in the
entire group (n ¼ 591) was 0.801. The frequencies of genotypes
4b4b, 4a4b, and 4a4a were 64.2%, 31.7%, and 4.1%, respectively,
which corresponded to the data reported for other European pop-
ulations [20,29].
No association of the 4a/4b polymorphism with the BP param-
eters prior to pregnancy was determined (p > 0.05) (Table 2).
Pregnant womenwith genotype 4a4a had higher DBP (р ¼ 0.02)
andmore pronounced changes in DBP and MAP during gestation as
compared to the carriers of allele 4b (genotypes 4b4b and 4a4b)
(Table 2).
The results of the multiple regression analysis suggested that
age, BMI, preeclampsia and the 4a/4b polymorphism are associated
with DBP and MAP at the end of gestation (Table 3). Overall, this
polymorphism accounts of about 38e65% variation of the BP
parameters in pregnant women at the end of gestation.
The results of the univariate analysis suggested that the 4а/4b
polymorphism is associated with the BP parameters in women at
the end of pregnancy both individually and through the interaction
with age, BMI and preeclampsia.
Only in the women with elevated BMI (more 25 kg/m2), the 4a/
4b eNOS polymorphism was associated with the blood pressure
parameters at the end of pregnancy (Table 4). In this group, the
Table 1
The biomedical and clinical characteristics of the study participants.
Value variables, Ме (Q25-Q75)
Number 591
Age, year 26.0 (24.0e31.0)
Height, m 1.65 (1.62e1.68)
Before Pregnancy During pregnancy (37e40 weeks term)
Weight, kg 70.0 (59.0e81.7) 79.3 (71.6e90.4)
BMI, kg/m2 23.0 (21.2e26.9) 29.2 (26.4e33.8)
Pregnant women without preeclampsia Pregnant women with preeclampsia
SBP, mmHg 110.0 (110.0e120.0) 130.0 (115.0e145.0) 110.0 (110.0e120.0) 140.0 (135.0e150.0)
DBP, mmHg 70.0 (70.0e80.0) 80.0 (75.0e90.0) 70.0 (70.0e75.0) 90.0 (85.0e100.0)
PBP, mmHg 40.0 (40.0e45.0) 50.0 (40.0e55.0) 40.0 (40.0e40.0) 50.0 (50.0e60.0)
MAP, mmHg 83.3 (81.7e93.3) 100.0 (88.3e110.0) 85.0 (83.3e90.0) 106.7 (103.3e116.7)
DMAP, mmHg 13.3 (3.3e23.3) 5.0 (0.0e10.0) 25.0 (20.0e35.0)
DSBP, mmHg 20.0 (10.0e30.0) 0.0 (0.0e10.0) 20.0 (10.0e25.0)
DDBP, mmHg 10.0 (0.0e20.0) 3.3 (0.0e8.3) 20.0 (13.3e28.3)
Hypotension 113 (19.1%) 24 (4.1%)
Normotension 417 (70.6%) 261 (44.2%)
Hypertension 61 (10.3%) 306 (51.7%)
Abbreviations: Me, median; Q25-Q75, interquartile range; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PBP, pulse blood pressure; MAP,
mean arterial pressure; D MAP, change of mean arterial pressure during gestation; DSBP, change of systolic blood pressure; DDBP, change of diastolic blood pressure.
Table 2
Association of the 4a/4b polymorphism of the eNOS gene with blood pressure parameters in women prior to pregnancy and women at the end of pregnancy, Me (Q25-
Q75).
Parameters of blood pressure Genotypes р
4b4bþ4a4b (n ¼ 562) 4a4a (n ¼ 24)
Women prior to pregnancy
SBP, mmHg. 110.0 (110.0e120.0) 110.0 (107.5.0e115.0) 0.4
DBP, mmHg 70.0 (70.0e80.0) 70.0 (62.5e70.0) 0.1
PBP, mmHg 40.0 (40.0e45.0) 40.0 (40.0e47.5) 0.6
MAP, mmHg 83.3 (83.3e90.0) 83.3 (76.7e85.0) 0.2
Women at the end of pregnancy
SBP, mmHg. 130.0 (120.0e145.0) 140.0 (120.0e157.5) 0.1
DBP, mmHg 80.0 (75.0e90.0) 90.0 (80.0e100.0) 0.02
PBP, mmHg 50.0 (40.0e55.0) 50.0 (40.0e57.0) 0.6
MAP, mmHg 100.0 (83.3e110.0) 110.0 (95.0e117.5) 0.05
DMAP, mmHg 13.3 (5.0e23.3) 25.0 (5.8e33.3) 0.03
DSBP, mmHg 20.0 (5.0e30.0) 30.0 (10.0e40.0) 0.1
DDBP, mmHg 10.0 (0.0e20.0) 20.0 (7.5e30.0) 0.02
Abbreviations: Me, median; Q25-Q75, interquartile range; P, p-value for ManneWhitney test; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; PBP, pulse blood pressure; MAP, mean arterial pressure during gestation; DMAP, change of mean arterial pressure; DSBP, change of systolic blood pressure;
DDBP, change of diastolic blood pressure.
Table 3
Results of the multiple regression analysis for interaction effect between the age, height, preeclampsia, genotypes of the 4a/4b eNOS polymorphism and blood pressure
parameters at the end of pregnancy.
Parameters Beta Student's p R2 F-test, p
SBP Age 0.11 <0.0001 0.65 <0.0001
BMI 0.17 <0.0001
preeclampsia 0.72 <0.0001
4a/4b eNOS 0.05 0.037
DBP Age 0.09 0.002 0.58 <0.0001
BMI 0.12 <0.0001
preeclampsia 0.70 <0.0001
4a/4b eNOS 0.06 <0.025
PBP Age 0.10 0.003 0.38 <0.0001
BMI 0.17 <0.0001
preeclampsia 0.52 <0.0001
4a/4b eNOS 0.02 <0.46
MAP Age 0.10 0.0001 0.64 <0.0001
BMI 0.14 <0.0001
preeclampsia 0.72 <0.0001
4a/4b eNOS 0.06 <0.02
Abbreviations: Beta, standardised regression coefﬁcients; R2, correlation coefﬁcient; Student's p, p-value for Student's t-test; P, p-value for F-test; BMI, body mass index; SBP,
systolic blood pressure; DBP, diastolic blood pressure; PBP, pulse blood pressure; MAP, mean arterial pressure during gestation.
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compared to the 4b4b and 4a4b genotypes.
The results of the univariate regression analysis suggested that
the 4a/4b polymorphism is associated with the BP parameters in
overweight and obese women (BMI>25) at the end of pregnancy
both individually and through the interaction with age, BMI and
preeclampsia.
The pregnant womenwith preeclampsia had a higher frequency
of the 4a4a genotype as compared to the women without pre-
eclampsia (4.7% and 2.9%, respectively), but these differences were
not statistically signiﬁcant (OR ¼ 1.63, 95% CI 0.60e4.68, p ¼ 0.42).
Changes in DBP were more pronounced in healthy pregnant
women with genotype 4a4a than in the women with either geno-
type 4b4b or 4a4b (р ¼ 0.02, Table 5).
Likewise, the 4a4a genotype carriers with preeclampsia had
higher DBP at the end of pregnancy as compared to the 4b4b and
4a4b genotype carriers (р ¼ 0.04).
Discussion
The results of the present study suggest that genotype 4a4a of
the eNOS gene is associated with higher levels of diastolic blood
pressure in pregnant women and with more pronounced dynamics
of the diastolic and mean arterial pressure in the course ofTable 4
Association of the 4a/4b polymorphism of the eNOS gene with blood pressure in women
BMI Blood pressure parameters Genotypes
4b4b
1
Underweight (BMI <18.5) N 35
BMI, kg/m2 18.9 (18.2e19.3)
SBP, mmHg 130.0 (115.0e135.0)
DBP, mmHg 80.0 (75.0e90.0)
PBP, mmHg 40.0 (40.0e50.0)
MAP, mmHg 96.7 (88.3e103.3)
DMAP, mmHg 13.3 (6.7e20.0)
DSBP, mmHg 20.0 (10.0e30.0)
DDBP, mmHg 10.0 (5.0e20.0)
Normal weight
(BMI 18.5e24.9)
N 203
BMI, kg/m2 22.0 (21.0e23.0)
SBP, mmHg. 120.0 (110.0e140.0)
DBP, mmHg 80.0 (70.0e90.0)
PBP, mmHg 45.0 (40.0e50.0)
MAP, mmHg 93.3 (83.3e106.7)
DMAP, mmHg 10.0 (3.3e21.7)
DSBP, mmHg 15.0 (5.0e30.0)
DDBP, mmHg 10.0 (0.0e20.0)
Overweight (BMI >25.0) N 139
BMI, kg/m2 28.9 (26.4e31.8)
SBP, mmHg. 140.0 (130.0e150.0)
DBP, mmHg 90.0 (80.0e100.0)
PBP, mmHg 50.0 (45.0e60.0)
MAP, mmHg 106.7 (100.0e116.7)
DMAP, mmHg 16.7 (8.3e23.3)
DSBP, mmHg 25.0 (10.0e30.0)
DDBP, mmHg 10.0 (10.0e20.0)
Overweight (BMI >29.9) N 58
BMI, kg/m2 32.4 (30.9e36.7)
SBP, mmHg. 150.0 (140.0e160.0)
DBP, mmHg 90.0 (80.0e100.0)
PBP, mmHg 55.0 (50.0e60.0)
MAP, mmHg 110.0 (103.3e120.0)
DMAP, mmHg 15.0 (6.7e23.3)
DSBP, mmHg 20.0 (10.0e30.0)
DDBP, mmHg 10.0 (5.0e20.0)
Abbreviations: Me, median; Q25-Q75, interquartile range; P, p-value for ManneWhitn
pressure; PBP, pulse blood pressure; MAP, mean arterial pressure during gestation; DMA
change of diastolic blood pressure.pregnancy (p ¼ 0.02e0.03). Pregnant women with the 4a4a ge-
notype and increased body mass index had high systolic, diastolic,
and mean arterial pressure (p ¼ 0.001e0.02). In the group of
pregnant women with preeclampsia, the 4a4a genotype is associ-
ated with a higher level of diastolic blood pressure at the end of
pregnancy (p ¼ 0.04), whereas in women without preeclampsia
this genotype was associated with more pronounced changes in
this type of blood pressure during pregnancy (p ¼ 0.02).
Endothelial nitric oxide synthase is synthesized predominantly
in endothelium of blood vessels and catalyzes synthesis of nitrogen
oxide (NO) from L-arginine. NO activates guanylate cyclase, which
synthesizes 30-50-cyclic guanosine monophosphate. The latter
promotes relaxation of smooth muscles of blood vessel walls and
vasodilation [6].
Some researchers suggested that the 4a/4b polymorphism may
be linked to other functional polymorphisms in the regulatory re-
gions of the eNOS gene. For example, haplotype 786C/4b/894G
was associated with a reduced risk of arterial hypertension [32].
EarlierWang et al. [33] reported the highest transcription activity of
the 786C/4b haplotype.
The higher level of arterial blood pressure in pregnant women
with genotype 4a4a determined in our study may be explained by
lower production of NO in these genotype carriers and, respec-
tively, its lower vasodilation effect.with different BMI at the end of pregnancy (Ме, Q25-Q75).
Differences between the
genotypes, р
4a4b
2
4a4a
3
1e2 2e3 1e3
20 0
18.8 (18.2e19.3) e 0.8 e e
130.0 (110.0e130.0) e 0.5 e e
80.0 (70.0e90.0) e 0.9 e e
40.0 (40.0e45.0) e 0.3 e e
96.7 (83.3e103.3) e 0.8 e e
12.5 (5.8e26.7) e 0.9 e e
17.5 (10.0e30.0) e 0.8 e e
10.0 (7.5e20.0) e 0.6 e e
98 12
22.1 (21.0e23.1) 22.6 (21.1e23.9) 0.8 0.3 0.2
130.0 (120.0e140.0) 120.0 (110.0e145.0) 0.2 0.5 0.9
80.0 (70.0e90.0) 90.0 (70.0e90.0) 0.3 1.0 0.8
45.0 (40.0e55.0) 40.0 (40.0e50.0) 0.1 0.2 0.5
98.3 (86.7e106.7) 100.0 (83.3e110.0) 0.3 0.8 1.0
13.3 (5.0e23.3) 23.3 (5.8e33.3) 0.4 0.2 0.1
20.0 (5.0e30.0) 20.0 (5.0e37.5) 0.3 0.6 0.3
10.0 (0.0e20.0) 20.0 (7.5e30.0) 0.4 0.1 0.1
65 11
27.7 (25.7e32.2) 30.1 (27.2e33.9) 0.1 0.2 0.5
140.0 (130.0e150.0) 150.0 (140.0e180.0) 0.7 0.02 0.009
90.0 (80.0e100.0) 100.0 (100.0e110.0) 0.7 0.001 0.002
50.0 (50.0e60.0) 50.0 (50.0e70.0) 0.3 0.4 0.2
106.7 (96.7e116.7) 116.7 (113.3e133.3) 1.0 0.005 0.003
16.7 (6.6e25.0) 23.3 (3.3e38.3) 0.8 0.2 0.1
20.0 (10.0e30.0) 30.0 (10.0e45.0) 0.7 0.2 0.2
10.0 (0.0e25.0) 20.0 (0.0e35.0) 1.0 0.2 0.2
22 5
33.7 (32.2e36.8) 33.9 (31.6e34.5) 0.6 0.9 1.0
147.5 (140.0e155.0) 170.0 (150.0e170.0) 1.0 0.1 0.1
90.0 (90.0e100.0) 100.0 (100.0e110.0) 1.0 0.1 0.1
55.0 (50.0e60.0) 60.0 (50.0e70.0) 1.0 0.4 0.4
109.2 (103.3e118.3) 123.3 (116.7e130.0) 1.0 0.1 0.1
17.5 (10.0e21.7) 10.0 (3.3e23.3) 0.6 0.7 1.0
20.0 (15.0e30.0) 10.0 (10.0e30.0) 0.6 0.6 1.0
10.0 (0.0e20.0) 10.0 (0.0e20.0) 0.6 0.8 0.9
ey test; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood
P, change of mean arterial pressure; DSBP, change of systolic blood pressure; DDBP,
Table 5
Association of the 4a/4b polymorphismwith blood pressure inwomenwith/without
preeclampsia at the end of pregnancy, Me (Q25-Q75).
Blood pressure parameters Genotypes р
4b4b+4a4b 4a4a
Pregnant women without preeclampsia (n ¼ 204)
N 198 6
SBP, mmHg. 110.0 (110.0e120.0) 112.5 (110.0e120.0) 0.7
DBP, mmHg 70.0 (70.0e75.0) 70.0 (70.0e90.0) 0.5
PBP, mmHg 40.0 (40.0e45.0) 40.0 (30.0e40.0) 0.4
MAP, mmHg 85.0 (83.3e90.0) 84.2 (83.3e100.0) 0.6
DMAP, mmHg 3.3 (0.0e6.7) 10.8 (3.3e35.0) 0.1
DSBP, mmHg 5.0 (0.0e10.0) 12.5 (0.0e35.0) 0.3
DDBP, mmHg 0.0 (0.0e10.0) 10.0 (5.0e35.0) 0.02
Pregnant women with preeclampsia (n ¼ 382)
N 364 18
SBP, mmHg. 140.0 (135.0e150.0) 150.0 (140.0e170.0) 0.1
DBP, mmHg 90.0 (85.0e100.0) 100.0 (90.0e100.0) 0.04
PBP, mmHg 50.0 (50.0e60.0) 50.0 (50.0e70.0) 0.6
MAP, mmHg 106.7 (102.5e116.7) 116.7 (106.7e123.3) 0.1
DMAP, mmHg 20.0 (13.3e27.5) 28.3 (10.0e33.3) 0.2
DSBP, mmHg 25.0 (20.0e35.0) 30.0 (10.0e45.0) 0.4
DDBP, mmHg 20.0 (10.0e25.0) 20.0 (10.0e30.0) 0.2
Abbreviations: Me, median; Q25-Q75, interquartile range; P, p-value for Man-
neWhitney test; SBP, systolic blood pressure; DBP, diastolic blood pressure; PBP,
pulse blood pressure; MAP, mean arterial pressure; DMAP, change of mean arterial
pressure during gestation; DSBP, change of systolic blood pressure; DDBP, change of
diastolic blood pressure.
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blood pressure in pregnant women have reported inconsistent re-
sults. Most of these studies were about a possible role of the eNOS
gene polymorphisms in development of preeclampsia. Hocher et al.
[20] did not ﬁnd any differences in MAP between the 4a/4b geno-
types of eNOS in a sample of 2186 pregnant Caucasian women.
Likewise, no association of the 4a/4b polymorphism was found
with either preeclampsia [22] or arterial blood pressure in pregnant
women with preeclampsia from different ethnic populations
[8,21,23].
Chen et al. [19] reported signiﬁcantly lower frequency of allele
4a of the 4a/4b polymorphism in pregnant Chinese women with
preeclampsia than in the controls. On the contrary, pregnant
Mexican women with preeclampsia had higher frequency of this
allele as compared to the controls [18]. Also, the carriers of allele 4a
with preeclampsia had higher SBP as compared to the 4b4b ge-
notypes [18].
Groten et al. reported an association of allele 4awith the 1.7-fold
increased risk of preeclampsia in Caucasian and African women
regardless of ethnicity, age, and parity [16].
Four meta-analyses also yielded inconsistent results. Twometa-
analyses of 18 [34] and 11 [22] studies reported an association of
allele 4a with a risk of preeclampsia, whereas two others of 33 and
41 studies did not [35,36].
The inconsistency in the above results may be attributed to the
interethnic differences in allele frequencies of the 4a/4b poly-
morphism [18,21,22,36], and, respectively, different importance of
the polymorphism for the hypertensive disorder at pregnancy in
populations of different ethnicity. This assumption is supported by
previous studies, which suggested interethnic differences in pop-
ulation genetic structure as an important factor for the observed
differences in prevalence of some complex traits [37,38]. Further
studies in different ethnicities are needed to resolve this
inconsistency.
The results of this study suggest that the 4a/4b polymorphism of
eNOS is associated with some parameters of arterial blood pressure
in pregnant women of Central Russia. In particular, genotype 4a4aof the polymorphism may confer higher level of arterial blood
pressure at pregnancy. In addition, overweight and obesity seem to
be important cofactors contributing to the BP parameters in preg-
nant women, Further studies on larger samples of various ethnic-
ities are needed to validate the results of the present study.
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